Search

Your search keyword '"Mohanan PV"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Mohanan PV" Remove constraint Author: "Mohanan PV"
159 results on '"Mohanan PV"'

Search Results

51. Role of immunoglobulin and antibodies in disease management.

52. Thermal deactivation of α-amylase immobilized magnetic chitosan and its modified forms: A kinetic and thermodynamic study.

53. In vitro and In vivo toxicity analysis of zinc selenium/zinc sulfide (ZnSe/ZnS) quantum dots.

54. Water dispersible ZnSe/ZnS quantum dots: Assessment of cellular integration, toxicity and bio-distribution.

55. Dextran stabilized fullerene soot induced toxicity on alveolar epithelial cells (A549 cells).

56. Organ distribution and biological compatibility of surface-functionalized reduced graphene oxide.

57. Toxicity of dextran stabilized fullerene C 60 against C6 Glial cells.

58. Chitra Disinfection Gateway for the Management of COVID 19 in Public Entry Places.

59. Conformity of dextran-coated fullerene C70 with L929 fibroblast cells.

60. Zinc oxide nanoparticle induced neurotoxic potential upon interaction with primary astrocytes.

61. Bio-interactions and risks of engineered nanoparticles.

62. Black phosphorus, a prospective graphene substitute for biomedical applications.

63. Cytoskeletal synchronization of CHO cells with polymer functionalized fullerene C 60 .

64. Comprehensive Application of Graphene: Emphasis on Biomedical Concerns.

65. In vitro interaction and biocompatibility of titanate nanotubes with microglial cells.

66. Heterocyclic Schiff bases as non toxic antioxidants: Solvent effect, structure activity relationship and mechanism of action.

67. Preclinical evaluation of hydrogel sealed fluropassivated indigenous vascular prosthesis.

68. Zinc oxide nanoparticles mediated cytotoxicity, mitochondrial membrane potential and level of antioxidants in presence of melatonin.

69. Raman spectroscopy for the detection of organ distribution and clearance of PEGylated reduced graphene oxide and biological consequences.

70. Investigation of chronic toxicity of hydroxyapatite nanoparticles administered orally for one year in wistar rats.

71. Preclinical safety and efficacy evaluation of 'BioCaS' bioactive calcium sulfate bone cement.

72. Synthesis, characterization and biological studies of Schiff bases derived from heterocyclic moiety.

73. Engineered Nanoparticles with Antimicrobial Property.

74. Toxicological evaluation of dextran stabilized iron oxide nanoparticles in human peripheral blood lymphocytes.

75. Immobilization of diastase α-amylase on nano zinc oxide.

76. Toxicity, toxicokinetics and biodistribution of dextran stabilized Iron oxide Nanoparticles for biomedical applications.

77. Effect of surface-modified superparamagnetic iron oxide nanoparticles (SPIONS) on mast cell infiltration: An acute in vivo study.

78. Hepatotoxicity evaluation of dextran stabilized iron oxide nanoparticles in Wistar rats.

79. Safety and biocompatibility of graphene: A new generation nanomaterial for biomedical application.

80. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study.

81. Engineered Zinc Oxide Nanoparticles; Biological Interactions at the Organ Level.

82. Integration of Rabbit Adipose Derived Mesenchymal Stem Cells to Hydroxyapatite Burr Hole Button Device for Bone Interface Regeneration.

83. In vitro hematological and in vivo immunotoxicity assessment of dextran stabilized iron oxide nanoparticles.

84. Investigation on cellular interactions of astrocytes with zinc oxide nanoparticles using rat C6 cell lines.

85. Characterizing the biocompatibility and tumor-imaging capability of Cu₂S nanocrystals in vivo.

86. Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties.

87. Assessing the systemic toxicity in rabbits after sub acute exposure to ocular irritant chemicals.

88. Stem Cells, a New Generation Model for Predictive Nano Toxicological Assessment.

89. Assessment of Immunotoxicity of Dextran Coated Ferrite Nanoparticles in Albino Mice.

91. Zinc oxide nanoparticles induced oxidative stress in mouse bone marrow mesenchymal stem cells.

92. An in vitro study on the interaction of hydroxyapatite nanoparticles and bone marrow mesenchymal stem cells for assessing the toxicological behaviour.

93. Interfacing of dextran coated ferrite nanomaterials with cellular system and delayed hypersensitivity on Guinea pigs.

94. Cells-nano interactions and molecular toxicity after delayed hypersensitivity, in guinea pigs on exposure to hydroxyapatite nanoparticles.

95. In vitro evaluation of antioxidant defense mechanism and hemocompatibility of mauran.

96. Effect of fibrin glue on antioxidant defense mechanism, oxidative DNA damage and chromosomal aberrations.

97. Analysis of mitochondrial DNA damage using 8-hydroxy 2'deoxyguanosine on in vitro and in vivo exposure of biomaterials.

98. Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies.

99. Analysis of IL-1 β release from cryopreserved pooled lymphocytes in response to lipopolysaccharide and lipoteichoic acid.

100. Detection of interleukin -1β from isolated human lymphocyte in response to lipopolysaccharide and lipoteichoic acid.

Catalog

Books, media, physical & digital resources